Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression.
Clin Mol Hepatol. 2024 Apr;30(2):247-262. doi: 10.3350/cmh.2023.0449. Epub 2024 Jan 26.
Clin Mol Hepatol. 2024.
PMID: 38281815
Free PMC article.
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin.
Kim HY, Otgontenger U, Kim JW, Lee YJ, Kim SB, Lim SC, Kim YM, Kang KW.
Kim HY, et al.
Arch Pharm Res. 2023 Mar;46(3):149-159. doi: 10.1007/s12272-023-01438-1. Epub 2023 Mar 10.
Arch Pharm Res. 2023.
PMID: 36894745
Free PMC article.
Item in Clipboard
Immunopathogenesis of liver fibrosis in steatotic liver disease.
Woo C, Jeong WI.
Woo C, et al.
Clin Mol Hepatol. 2024 Apr;30(2):299-302. doi: 10.3350/cmh.2024.0113. Epub 2024 Feb 19.
Clin Mol Hepatol. 2024.
PMID: 38373420
Free PMC article.
No abstract available.
Item in Clipboard
Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression".
Jung S, Yoon S, Park JH, Lee YS, Yoo KH.
Jung S, et al.
Clin Mol Hepatol. 2024 Apr;30(2):287-290. doi: 10.3350/cmh.2024.0136. Epub 2024 Feb 23.
Clin Mol Hepatol. 2024.
PMID: 38390704
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite